A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting vulnerable groups that are most at risk of serious illness, including older adults and infants.
RSV is a common virus that causes coughs and colds but can also lead to life-threatening lung infections like pneumonia. Children under the age of two are at the highest risk of severe RSV infection and death, with older adults also vulnerable.
An international group of researchers analyzed 14 clinical trials with over 100,000 participants, including older adults, pregnant women, women of childbearing age, and children...
Read More
Recent Comments